Asset Details
Do you wish to reserve the book?
Neutrophil Gelatinase–Associated Lipocalin in Dogs with Naturally Occurring Renal Diseases
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Neutrophil Gelatinase–Associated Lipocalin in Dogs with Naturally Occurring Renal Diseases
Do you wish to request the book?
Neutrophil Gelatinase–Associated Lipocalin in Dogs with Naturally Occurring Renal Diseases
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Neutrophil Gelatinase–Associated Lipocalin in Dogs with Naturally Occurring Renal Diseases
2014
Overview
BACKGROUND: Neutrophil gelatinase–associated lipocalin (NGAL) is released from renal tubular cells after injury and serves in humans as a real‐time indicator of active kidney damage, including acute kidney injury (AKI) and chronic kidney disease (CKD). However, NGAL concentrations in dogs with naturally occurring AKI or CKD rarely have been explored in detail. HYPOTHESIS/OBJECTIVES: The goal of this study was to evaluate whether NGAL can serve as a useful biomarker in dogs with naturally occurring renal disease. ANIMALS: Client‐owned dogs with renal disease (57) and control dogs without any disease (12) were examined. METHODS: Serum NGAL (sNGAL) and urine NGAL (uNGAL) concentrations were measured in each animal by a newly developed ELISA system. Demographic, hematologic, and serum biochemical data were recorded. Survival attributable to AKI and CKD was evaluated at 30 days and 90 days, respectively. RESULTS: Serum and urine NGAL concentrations in azotemic dogs were significantly higher than in nonazotemic dogs and were highly correlated with serum creatinine concentration (P < .05). Among CKD dogs, death was associated with significantly higher sNGAL and uNGAL concentrations compared with survivors. Receiver‐operating characteristic curve (ROC) analysis showed that sNGAL was better than serum creatinine concentration when predicting clinical outcomes for CKD dogs (P < .05). The best cutoff point for sNGAL was 50.6 ng/mL, which gave a sensitivity and a specificity of 76.9 and 100%, respectively. Furthermore, dogs that had higher concentrations of sNGAL survived for a significantly shorter time. CONCLUSION: sNGAL is a useful prognostic marker when evaluating dogs with CKD.
Publisher
J.B. Lippincott,Blackwell Publishing Ltd,Oxford University Press,John Wiley and Sons Inc
Subject
/ Acute Kidney Injury - diagnosis
/ Acute Kidney Injury - veterinary
/ Animals
/ Azotemia
/ death
/ Diabetes
/ Dogs
/ enzyme-linked immunosorbent assay
/ Enzyme-Linked Immunosorbent Assay - veterinary
/ Female
/ humans
/ Kidney Diseases - veterinary
/ kidneys
/ Male
/ medicine
/ Original
/ Outcome
/ Plasma
/ Proto-Oncogene Proteins - blood
/ Renal Insufficiency, Chronic - blood
/ Renal Insufficiency, Chronic - diagnosis
/ Renal Insufficiency, Chronic - veterinary
/ Survival
/ urine
